We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
+11.17%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$86.9B
AUM Growth
+$1.22B
(+1.4%)
Cap. Flow
-$8.13B
Cap. Flow
% of AUM
-9.35%
Top 10 Holdings %
Top 10 Hldgs %
9.21%
Holding
2,795
New
93
Increased
976
Reduced
1,389
Closed
209
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$213M |
| 2 |
Carrier Global
CARR
|
+$154M |
| 3 |
Darden Restaurants
DRI
|
+$149M |
| 4 |
VictoryShares WestEnd US Sector ETF
MODL
|
+$141M |
| 5 |
Zimmer Biomet
ZBH
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$504M |
| 2 |
Archer Daniels Midland
ADM
|
+$183M |
| 3 |
CDW
CDW
|
+$150M |
| 4 |
Corteva
CTVA
|
+$146M |
| 5 |
SBA Communications
SBAC
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16% |
| 2 | Industrials | 14.52% |
| 3 | Financials | 13.87% |
| 4 | Healthcare | 10.7% |
| 5 | Consumer Discretionary | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Neurocrine Biosciences
NBIX
$16.7B
| $13.5M | 0.02% |
113,338
+15,478
| +16% | +$1.81M |
|
902
AstraZeneca
AZN
$251B
| $13.5M | 0.02% |
99,692
-4,831
| -5% | -$606K |
|
903
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $13.5M | 0.02% |
346,292
+276,220
| +394% | +$10.5M |
|
904
BioMarin Pharmaceuticals
BMRN
$12.9B
| $13.5M | 0.02% |
130,100
-605,370
| -82% | -$56.8M |
|
905
Incyte
INCY
$24.8B
| $13.4M | 0.02% |
167,039
-115,303
| -41% | -$8.82M |
|
|
GTM
906
ZoomInfo Technologies
GTM
$1.24B
| $13.4M | 0.02% |
445,037
-567,375
| -56% | -$19.6M |
|
907
Nordson
NDSN
$17.2B
| $13.4M | 0.02% |
56,325
-68,455
| -55% | -$15.6M |
|
908
Sun Communities
SUI
$14.5B
| $13.4M | 0.02% |
93,505
-340,721
| -78% | -$46.5M |
|
909
Magnite
MGNI
$3.48B
| $13.3M | 0.02% |
1,257,147
+1,244,166
| +9,585% | +$11.4M |
|
910
Buckle
BKE
$2.39B
| $13.3M | 0.02% |
293,376
-71,152
| -20% | -$2.87M |
|
|
FRC
911
DELISTED
First Republic Bank
FRC
| $13.3M | 0.02% |
109,091
+38,061
| +54% | +$4.64M |
|
912
Verra Mobility
VRRM
$728M
| $13.3M | 0.02% |
960,851
-171,133
| -15% | -$2.6M |
|
|
MDC
913
DELISTED
M.D.C. Holdings, Inc.
MDC
| $13.3M | 0.02% |
419,533
+303,943
| +263% | +$9.39M |
|
914
Brown-Forman Class B
BF.B
$12.9B
| $13.2M | 0.02% |
200,827
+14,155
| +8% | +$960K |
|
|
SPTN
915
DELISTED
SpartanNash
SPTN
| $13.1M | 0.02% |
433,832
-129,873
| -23% | -$4.23M |
|
916
NewMarket
NEU
$8.29B
| $13.1M | 0.02% |
42,088
+26,281
| +166% | +$8.08M |
|
917
Targa Resources
TRGP
$56.3B
| $13.1M | 0.02% |
178,011
+35,232
| +25% | +$2.46M |
|
918
Moelis & Co
MC
$4.71B
| $13.1M | 0.02% |
340,347
+257,256
| +310% | +$10.4M |
|
|
RXDX
919
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $13M | 0.02% |
118,407
+110,292
| +1,359% | +$7.15M |
|
920
Sturm, Ruger & Co
RGR
$593M
| $12.9M | 0.01% |
255,252
-56,910
| -18% | -$3.09M |
|
921
Weyerhaeuser
WY
$18.1B
| $12.9M | 0.01% |
416,406
+26,768
| +7% | +$830K |
|
922
Loews
L
$23.3B
| $12.9M | 0.01% |
220,643
+79,585
| +56% | +$4.44M |
|
923
iShares Core MSCI Europe ETF
IEUR
$9.15B
| $12.9M | 0.01% |
270,682
-46,156
| -15% | -$2.08M |
|
924
PJT Partners
PJT
$4.27B
| $12.8M | 0.01% |
173,827
+167,978
| +2,872% | +$12.6M |
|
925
Etsy
ETSY
$7.5B
| $12.7M | 0.01% |
105,984
+58,581
| +124% | +$6.7M |
|
Similar funds
VGA
Victory Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Victory Capital Management held 2,795 positions worth $86.9B, up 1.4% from $85.7B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
Victory Capital Management withdrew a net $8.13B in Q4 2022, closing 209 positions and reducing 1,389 holdings. Its most notable exit was Alleghany Corp, an estimated $504M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Financials.
Against the trend, Victory Capital Management opened a new position in VictoryShares WestEnd US Sector ETF worth $140M.
- Victory Capital Management's largest Q4 2022 buy was VictoryShares WestEnd US Sector ETF: 5,259,612 shares worth $140M.
- Victory Capital Management added most to T. Rowe Price in Q4 2022, an estimated $213M increase.
- Victory Capital Management's biggest Q4 2022 reduction was Archer Daniels Midland, cutting an estimated $183M.
- Victory Capital Management fully exited Alleghany Corp in Q4 2022, selling an estimated $504M.
- Victory Capital Management's ten largest holdings make up 9.2% of its $86.9B portfolio in Q4 2022.
- Victory Capital Management opened 93 new positions and closed 209 in Q4 2022.
- Victory Capital Management's portfolio value rose 1.4% quarter-over-quarter to $86.9B.
Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.